戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1               Surgical embolectomy and/or venoarterial ECMO were compared, between 2005 and 2019, for massive PE (MPE) ve
2                           Tracer uptake and PSMA expression were compared between benign and malignant tissue.
3                                     Variations in mortality were compared between centres and provinces within China.
4 , neuropsychological testing and emotional/behavioural data were compared between CTE and AD subjects at the time of deme
5 Clinical data, including CDI severity and CDI risk factors, were compared between discordant test results.
6 s vault, anterior chamber depth, and anterior chamber area, were compared between early PACD (PACS) and late PACD (PAC an
7                                          Biomarker measures were compared between groups using linear regression models a
8 tide), cardiac reverse remodeling, and health status scores were compared between groups using multivariate latent growth
9  (ED) visits, and outpatient clinic encounters before age 1 were compared between groups via logistic regression models.
10                               Length of hospital encounters were compared between groups via Mann-Whitney U test.
11 tment outcomes (cure, failure, death, or loss to follow-up) were compared between groups with respect to glycemic status
12                                Week 12 TFV-DP distributions were compared between groups with the Wilcoxon test.
13 ined as the proportion of patients with at least 1 adenoma) were compared between groups, with a noninferiority margin (r
14 ionProcedure: Patient demographics, VA, IOD, and stereopsis were compared between groups.
15 last HIV-1 RNA plasma viral load (pVL), and causes of death were compared between groups.
16 d conditions, endoscopic findings, treatments, and outcomes were compared between immunocompetent and immunocompromised.
17        Biopsy-proven acute rejection (BPAR) rates and types were compared between indigenous and nonindigenous recipients
18                            Respiratory outcomes at 48 hours were compared between infants treated with laser therapy unde
19          Rates of direct emergency department (ED) referral were compared between insurance types.
20                 Flare detection sensitivity and specificity were compared between 'minimal' baseline and 6 week sample CR
21 ncy department visit, psychiatric hospitalization, suicide) were compared between mothers and siblings and their controls
22 ges from pre to post-conditioning (DeltaMQST and DeltaTQST) were compared between OA and control dogs.
23                                          Treatment outcomes were compared between participants receiving bezlotoxumab (al
24                                            Obtained metrics were compared between participants with CF and control partic
25                            Sociodemographic characteristics were compared between participants with small burns (<=40% TB
26                          Epidemiology and clinical outcomes were compared between patients with all negative versus any p
27 al presentation, antiviral and immunosuppressive management were compared between patients with mild/moderate and severe
28  recurrence-free survival (RFS), and HCC recurrence (HCC-R) were compared between patients within MC (n = 3,570) and beyo
29                           Presence and quantity of shedding were compared between strains and seasons with adjustment for
30  absence of choroidal involvement, and quantitative metrics were compared between subgroups and normal control subjects.
31                                                       Means were compared between techniques and participants.
32                                                PET findings were compared between the 2 radiotracers and with reference-s
33       Geometric mean titers (GMTs) and seropositivity rates were compared between the different groups at different time
34                                          Prediction results were compared between the different methods and the true post
35        Specific procedure parameters and treatment regimens were compared between the group of eyes with and without ACI.
36                                   Rates of delayed bleeding were compared between the hemoclip and no-hemoclip groups.
37 ions with standard automated perimetry (SAP) global indices were compared between the human gradings vs the M2M DL-predic
38 d major cardiovascular and cerebrovascular events [MACCEs]) were compared between the matched groups using a stratified l
39 assess relative validity, calculated dietary folate intakes were compared between the MGDB and the EPIC nutrient database
40 ation dataset, the receiver operating characteristics (ROC) were compared between the models trained in the centralized a
41 entage, the control metric, were computed, and their values were compared between the normal and DR eyes.
42 e network and bridge centrality, and the network properties were compared between the outbreak and after peak.
43 dth, percentage of root coverage, patient-centered outcomes were compared between the two groups.
44      Perioperative complications and postoperative outcomes were compared between the two groups.
45 ardized mortality ratios, and standardized incidence ratios were compared between treatment groups and with the US popula
46      Changes in ECD, CV, and %HEX from baseline to 3 months were compared between treatment groups using 2-sample t tests
47                                       Precancerous outcomes were compared between unvaccinated and HPV-vaccinated women b
48                                        Quantitative metrics were compared between uveitis and control eyes.
49 nge in OCTA size, vessel density, and vessel length density were compared between visits as predictors of progression to
50    The number and distribution of unique symptom phenotypes were compared between women and men.